Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers approximately 520 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. In addition, the company exports its products. Ami Organics Limited was founded in 2004 and is based in Surat, India.
Stock data | 2023 | Change |
---|---|---|
Price | $16.47 | N/A |
Market Cap | $599.67M | N/A |
Shares Outstanding | 36.42M | 6.45% |
Employees | 602.00 | N/A |
Shareholder Equity | 5.94B | 13.73% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.72 | N/A |
P/S Ratio | 8.16 | N/A |
P/B Ratio | 0.10 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $73.53M | N/A |
Earnings | $9.93M | N/A |
EPS | 22.87 | N/A |
Earnings Yield | 1.39 | N/A |
Gross Margin | 0.4635 | N/A |
Operating Margin | 0.1788 | N/A |
Net income margin | 0.135 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $91.44M | N/A |
Total Debt | $429.26K | N/A |
Cash on Hand | $7.00M | N/A |
Debt to Equity | 0.0035 | 11.34% |
Cash to Debt | $16.30 | -77.65% |
Current Ratio | $2.89 | -13.01% |